DTIL – precision biosciences, inc. (US:NASDAQ)
Stock Stats
News
2/11
07:01 am
dtil
Low
Precision BioSciences Receives U.S. FDA Clearance of Investigational New Drug Application for First-in-Class PBGENE-DMD for Treatment of Duchenne Muscular Dystrophy
2/2
09:36 am
dtil
Medium
Registration for SOHO 2026 is now open; Register by June 10, 2026 to receive early registration rates [Yahoo! Finance]
1/12
08:55 am
dtil
Low
Precision BioSciences Sets Strategic Priorities for 2026 Focused on Continued Advancement of Clinical-Stage Programs PBGENE-HBV for Chronic Hepatitis B and PBGENE-DMD for Duchenne Muscular Dystrophy [Yahoo! Finance]
1/12
07:01 am
dtil
Medium
Precision BioSciences Sets Strategic Priorities for 2026 Focused on Continued Advancement of Clinical-Stage Programs PBGENE-HBV for Chronic Hepatitis B and PBGENE-DMD for Duchenne Muscular Dystrophy
1/7
08:00 am
dtil
Low
iECURE Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for ECUR-506 for Neonatal Onset Ornithine Transcarbamylase (OTC) Deficiency
11/3/2025
07:01 am
DTIL
-10.2%
MISS
8/7/2025
07:01 am
DTIL
-8.6%
MISS
5/15/2025
07:01 am
DTIL
-8.3%
MISS
3/26/2025
07:01 am
DTIL
-15.5%
MISS
2/11
07:15 am
dtil
Low
Form 8-K PRECISION BIOSCIENCES For: Feb 11
2/10
01:16 pm
dtil
Low
Form SCHEDULE 13G PRECISION BIOSCIENCES Filed by: Octagon Capital Advisors LP
1/27
10:10 am
dtil
Low
Form SCHEDULE 13G PRECISION BIOSCIENCES Filed by: Aberdeen Group plc
1/22
06:49 pm
dtil
Low
Form 4 PRECISION BIOSCIENCES For: Jan 20 Filed by: Amoroso Michael
1/22
06:49 pm
dtil
Low
Form 4 PRECISION BIOSCIENCES For: Jan 20 Filed by: Scimeca Dario
Show more
Top News Gainers
11/13 Precision BioSciences Inc (NASDAQ: DTIL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $21.00 price target on the stock. 24.6%
4/6 Form 8-K PRECISION BIOSCIENCES For: Apr 06 21.4%
11/6 Precision BioSciences Announces the Presentation of Initial Clinical Data Supporting the Safety and Clinical Activity of PBCAR0191, a Novel CD19 Targeted Allogeneic CAR T Therapy Candidate, at the American Society of Hematology Annual Meeting 18.6%
1/8 Form 4 PRECISION BIOSCIENCES For: Jan 06 Filed by: ANSARI ABID 17.3%
3/12 Form 3 PRECISION BIOSCIENCES For: Mar 10 Filed by: Germano Geno J 13.8%
4/28 Precision BioSciences Announces Presentations at the American Society of Gene & Cell Therapy 23rd Annual Meeting 6.8%
4/8 Precision BioSciences Inc (NASDAQ: DTIL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $19.00 price target on the stock. 6.4%
11/12 Form 10-Q PRECISION BIOSCIENCES For: Sep 30 5.7%
2/24 Precision BioSciences: Consider Taking Up A Small Position [Seeking Alpha] 5.4%
11/13 Form 3 PRECISION BIOSCIENCES For: Nov 08 Filed by: Buehler Kevin 5.3%
Top News Decliners
12/9 Precision BioSciences stock rises on early-stage CAR-T trial data [MarketWatch] -54.5%
3/12 Form 8-K PRECISION BIOSCIENCES For: Mar 12 -16.5%
4/15 Precision Biosciences Appoints Dora Alvarado as Senior Vice President of Human Resources -16.4%
8/9 Precision BioSciences Inc (NASDAQ: DTIL) is now covered by analysts at BTIG Research. They set a "buy" rating on the stock. -16.3%
4/2 Precision BioSciences Inc (NASDAQ: DTIL) was downgraded by analysts at Goldman Sachs Group Inc from a "buy" rating to a "neutral" rating. -15.9%
3/11 Precision BioSciences Strengthens Board of Directors with Appointment of Geno Germano -14.6%
1/15 Form 8-K/A PRECISION BIOSCIENCES For: Jan 15 -12.4%
1/13 Precision BioSciences Announces FDA Acceptance of IND for PBCAR269A, a BCMA Targeted Genome Edited Allogeneic CAR T Therapy Candidate for Multiple Myeloma -8.0%
9/25 Form 4 PRECISION BIOSCIENCES For: Sep 23 Filed by: KANE MATTHEW R. -7.7%
2/7 Form SC 13G PRECISION BIOSCIENCES Filed by: BlackRock Inc. -7.1%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3